These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1679388)

  • 1. Testing the abuse liability of anxiolytic and hypnotic drugs in humans.
    de Wit H; Griffiths RR
    Drug Alcohol Depend; 1991 Jun; 28(1):83-111. PubMed ID: 1679388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore.
    Evans SM; Critchfield TS; Griffiths RR
    Br J Addict; 1991 Dec; 86(12):1625-32. PubMed ID: 1686197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse liability of barbiturates and other sedative-hypnotics.
    Morgan WW
    Adv Alcohol Subst Abuse; 1990; 9(1-2):67-82. PubMed ID: 2198786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds.
    Griffiths RR; Johnson MW
    J Clin Psychiatry; 2005; 66 Suppl 9():31-41. PubMed ID: 16336040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative abuse liability of different benzodiazepines in drug abusers.
    Griffiths RR; Wolf B
    J Clin Psychopharmacol; 1990 Aug; 10(4):237-43. PubMed ID: 1981067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental abuse liability assessment of benzodiazepines.
    Woods JH
    J Psychoactive Drugs; 1983; 15(1-2):61-5. PubMed ID: 6136572
    [No Abstract]   [Full Text] [Related]  

  • 7. Principles of initial experimental drug abuse liability assessment in humans.
    Griffiths RR; Bigelow GE; Ator NA
    Drug Alcohol Depend; 2003 Jun; 70(3 Suppl):S41-54. PubMed ID: 12759196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of abuse liability of stimulant drugs in humans: a methodological survey.
    Foltin RW; Fischman MW
    Drug Alcohol Depend; 1991 Jun; 28(1):3-48. PubMed ID: 1679387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse liability of diphenhydramine in sedative abusers.
    Wolf B; Guarino JJ; Preston KL; Griffiths RR
    NIDA Res Monogr; 1989; 95():486-7. PubMed ID: 2577046
    [No Abstract]   [Full Text] [Related]  

  • 10. Addictive behaviors and benzodiazepines: 2. Are there differences between benzodiazepines in potential for physical dependence and abuse liability?
    Senay EC
    Adv Alcohol Subst Abuse; 1990; 9(3-4):53-64. PubMed ID: 1981124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A postmarketing study of relative abuse liability of hypnotic sedative drugs.
    Jaffe JH; Bloor R; Crome I; Carr M; Alam F; Simmons A; Meyer RE
    Addiction; 2004 Feb; 99(2):165-73. PubMed ID: 14756709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative abuse liability of triazolam: experimental assessment in animals and humans.
    Griffiths RR; Lamb RJ; Ator NA; Roache JD; Brady JV
    Neurosci Biobehav Rev; 1985; 9(1):133-51. PubMed ID: 2858078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benzodiazepines as drugs of abuse.
    Cole JO; Chiarello RJ
    J Psychiatr Res; 1990; 24 Suppl 2():135-44. PubMed ID: 1980692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse liability studies of opioid agonist-antagonists in humans.
    Preston KL; Jasinski DR
    Drug Alcohol Depend; 1991 Jun; 28(1):49-82. PubMed ID: 1884671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addictive behaviors and benzodiazepines: 1. Abuse liability and physical dependence.
    Senay EC
    Adv Alcohol Subst Abuse; 1989; 8(1):107-24. PubMed ID: 2565664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preference procedures for testing the abuse liability of drugs in humans.
    De Wit H
    Br J Addict; 1991 Dec; 86(12):1579-86. PubMed ID: 1786490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse liability of alprazolam relative to other commonly used benzodiazepines: a review.
    Rush CR; Higgins ST; Bickel WK; Hughes JR
    Neurosci Biobehav Rev; 1993; 17(3):277-85. PubMed ID: 7903805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.
    Licata SC; Rowlett JK
    Pharmacol Biochem Behav; 2008 Jul; 90(1):74-89. PubMed ID: 18295321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.